Cim 2024 Recifercept. Welcome to the cim 2024 transfer group page! The theme of the inaugural mrmr conference, which will be held.


Cim 2024 Recifercept

04/29/2024 pubmed natural disease course modeling of achondroplasia to evaluate the efficacy of recifercept in the absence of a placebo control arm in phase ii study. Recifercept is the most advanced rare disease candidate to become discontinued.

Cim 2024 Recifercept Images References :